Cargando…

Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations

BACKGROUND: Initial appropriate anti-infective therapy is associated with improved outcomes in patients with severe infections. In critically ill patients, altered pharmacokinetic (PK) behaviour is common and known to influence the achievement of PK/pharmacodynamic targets. OBJECTIVES: To describe p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jager, Nynke G L, van Hest, Reinier M, Xie, Jiao, Wong, Gloria, Ulldemolins, Marta, Brüggemann, Roger J M, Lipman, Jeffrey, Roberts, Jason A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443729/ https://www.ncbi.nlm.nih.gov/pubmed/32443147 http://dx.doi.org/10.1093/jac/dkaa187

Ejemplares similares

High unbound flucloxacillin fraction in critically ill patients
por: Wallenburg, Eveline, et al.
Publicado: (2021)

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients
por: Sime, Fekade B., et al.
Publicado: (2019)

Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro
por: Stolte, Maximilian, et al.
Publicado: (2020)

Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients
por: Zahr, Noël, et al.
Publicado: (2022)

Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies
por: Jansen, Anouk M. E., et al.
Publicado: (2023)

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction
por: Sime, Fekade B., et al.
Publicado: (2019)

Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study
por: Meenks, Sjoerd D., et al.
Publicado: (2023)

Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs
por: Moser, Stephan, et al.
Publicado: (2021)

Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid
por: Van Daele, Ruth, et al.
Publicado: (2021)

Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury
por: Ali, Serat-E, et al.
Publicado: (2023)

High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints
por: Jansen, Anouk M. E., et al.
Publicado: (2023)

Development and validation of a bioanalytical assay for the measurement of total and unbound teicoplanin in human serum
por: Mouton, J W A, et al.
Publicado: (2023)

Determination of total and unbound docetaxel in plasma by ultrafiltration and UPLC-MS/MS: application to pharmacokinetic studies
por: Sheu, Ming-Thau, et al.
Publicado: (2017)

Flucloxacillin and paracetamol induced pyroglutamic acidosis
por: Zand Irani, Anis, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study
por: Gijsen, Matthias, et al.
Publicado: (2021)

The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence
por: Barker, Charlotte I S, et al.
Publicado: (2023)

Unbound Plasma, Total Plasma, and Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation
por: Sikma, Maaike A., et al.
Publicado: (2019)

Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients
por: Sheng, Changcheng, et al.
Publicado: (2020)

Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection
por: Werumeus Buning, Annabel, et al.
Publicado: (2021)

Oral Flucloxacillin for Staphylococcal Osteomyelitis: Obsolete or Underused?
por: Tevell, Staffan, et al.
Publicado: (2020)

An update on drug-drug interactions for care of the acutely ill in the era of COVID-19
por: Patanwala, Asad E, et al.
Publicado: (2023)

Publisher Correction: Determination of total and unbound docetaxel in plasma by ultrafiltration and UPLC-MS/MS: application to pharmacokinetic studies
por: Sheu, Ming-Thau, et al.
Publicado: (2018)

Correction to: Unbound Plasma, Total Plasma and Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation
por: Sikma, Maaike A., et al.
Publicado: (2022)

Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
por: Guo, Tingjie, et al.
Publicado: (2022)

In healthy volunteers, taking flucloxacillin with food does not compromise effective plasma concentrations in most circumstances
por: Gardiner, Sharon J., et al.
Publicado: (2018)

Flucloxacillin bone and soft tissue concentrations assessed by microdialysis in pigs after intravenous and oral administration
por: Bendtsen, Mathias A. F., et al.
Publicado: (2021)

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
por: Preijers, Tim, et al.
Publicado: (2020)

Oral flucloxacillin and phenoxymethylpenicillin versus flucloxacillin alone for the emergency department outpatient treatment of cellulitis: study protocol for a randomised controlled trial
por: Quirke, Michael, et al.
Publicado: (2013)

Population pharmacokinetics and dosing optimization of unbound teicoplanin in Chinese adult patients
por: Fu, Wen-Qian, et al.
Publicado: (2022)

Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction
por: Alnasrallah, Basil, et al.
Publicado: (2016)

Broad-spectrum azoles and flucloxacillin: a dangerous match
por: Vangheluwe, Tine, et al.
Publicado: (2021)

2533. Cerebrospinal Fluid Penetration of Cefazolin and Flucloxacillin in Children
por: Boast, Alison, et al.
Publicado: (2023)

Mathematics unbound
por: Parshall, Karen Hunger, et al.
Publicado: (2002)

Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia
por: van der Heijden, Charlotte D.C.C., et al.
Publicado: (2019)

Potentials Unbounded Below
por: Curtright, Thomas
Publicado: (2010)

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
por: Sime, Fekade B., et al.
Publicado: (2018)

Characterization of Flucloxacillin-specific CD8+ T-cells in a mouse model
por: Nattrass, Ryan, et al.
Publicado: (2014)

Clinical factors predicting drug-induced liver injury due to flucloxacillin
por: Lindh, Mikaela, et al.
Publicado: (2018)

Oral Flucloxacillin for Treating Osteomyelitis: A Narrative Review of Clinical Practice
por: Preiss, Helga, et al.
Publicado: (2020)

Flucloxacillin/paracetamol: High-anion gap metabolic acidosis : case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_04u60upf9bd6bor872vptdblsm